Lupin Pharmaceuticals Inc. recalls Lisinopril and Hydrochlorothiazide…
Lupin Pharmaceuticals Inc. recalls Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg
- Published
- 23 Jul 2025
- Units affected
- 58,968 bottles
- Agency
- FDA
- Country
- United States
The hazard
Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, Manufactured by: Lupin Limited Nagpur-441 108, INDIA, NDC 68180-519-01
- Brand / company
- Lupin Pharmaceuticals Inc.
- Codes / lots
- Lot #: QA01081, Exp. Date April 2027
- Distribution
- Product was distributed nationwide within the United States.
- Recall status
- Completed
Source: U.S. Food and Drug Administration, published 23 Jul 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.